Search

everythinglearnresearchcommunity

for

Search:↓

The Turkish version of the MAIA-2 Scale is valid and reliable for patients at a dermatology clinic.

The CLASI is a reliable tool for measuring the severity of cutaneous lupus erythematosus.

New grading scale accurately measures hair loss severity and treatment effectiveness.

The PRECISE scale helps estimate how many grafts are needed for hair transplant based on the severity of hair loss.

The Greek DCQ is a reliable and valid tool for assessing dysmorphic concern.

Computer-aided imaging system accurately measures baldness in Chinese women with hair loss.

The SAAD-41 scale effectively measures the psychosocial impact of alopecia areata.

A new tool simplifies alopecia areata severity scoring but needs validation.

Hair shaft changes may be linked to CCCA, but their role is unclear.

The model improves understanding of androgen interactions by focusing on signal intensity and system capacity.

The model improves understanding of androgen interactions by focusing on signal intensity and system capacity.

CCCA is a scarring hair loss condition mainly in African descent women, possibly caused by genetics and hairstyling, treated with gentle hair care and medications.

The facial aging scale is a reliable tool for assessing skin aging and treatment effects.

A new reliable scale improves accuracy in measuring hair density and treatment response.

The InCISE score is a promising tool for assessing wound healing in head and neck surgery but needs more research for broader use.

The AAcQLI is a promising tool for assessing quality of life in children with alopecia areata.

CE-PTG is a better method for analyzing hair growth in androgenetic alopecia.

CE-PTG detects early hair follicle issues in balding areas, helping measure male hair loss.

You might not need to stop cancer treatment if you get a rare skin reaction from EGFR inhibitors, as skin treatments can help manage it.

Recognizing and managing skin side effects from chemotherapy improves patient quality of life and treatment success.

Scalp cooling effectively prevents hair loss during chemotherapy in most cases.

The pandemic likely caused delays in skin cancer assessments, leading to fewer early diagnoses and thicker melanomas.

Tofacitinib and baricitinib had an acceptable level of side effects in rheumatoid arthritis patients.

The new clinical trial design is promising but needs real-world trials to test its effectiveness and possible enhancements.

CCCA is a scarring hair disorder mainly affecting people of African descent, needing better awareness and treatment.

Two methods reliably measure scalp area and hair count.

Early diagnosis with trichoscopy can improve management and quality of life for CCCA patients.

The hair-pulling scale needs improvement for better accuracy and consistency.

High TSPEAR levels in colorectal cancer predict worse outcomes.

The two-factor model fits better for Chinese patients' understanding of illness causes than the original four-factor model.